Compounds > selegiline
Page last updated: 2024-08-23

selegiline and Brain Neoplasms

selegiline has been researched along with Brain Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engler, H; Kreimerman, I; Olivera, S; Savio, E; Vasilskis, E1
Breinbauer, R; Hermetter, A; Kreuzer, J; Krysiak, JM; Macheroux, P; Sieber, SA1
Suzuki, O1
Fahn, S; García de Yébenes, J; Mena, MA; Pardo, B1
Boulton, AA; Juorio, AV; Li, XM; Qi, J1
Aquilonius, SM; Bergström, M; Ekblom, J; Jossan, SS; Oreland, L; Walum, E1
Yu, PH; Zuo, D1

Reviews

1 review(s) available for selegiline and Brain Neoplasms

ArticleYear
[Current status of type A and type B monoamine oxidase (author's transl)].
    Seikagaku. The Journal of Japanese Biochemical Society, 1980, Volume: 52, Issue:3

    Topics: Animals; Brain Chemistry; Brain Neoplasms; Cattle; Clorgyline; Glioma; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Substrate Specificity

1980

Other Studies

6 other study(ies) available for selegiline and Brain Neoplasms

ArticleYear
Comparative In Vitro Study of
    Cancer biotherapy & radiopharmaceuticals, 2017, Volume: 32, Issue:9

    Topics: Astrocytes; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Deuterium; Glial Fibrillary Acidic Protein; Gliosis; Humans; Methionine; Monoamine Oxidase; Positron-Emission Tomography; Radiopharmaceuticals; Selegiline

2017
Activity-based probes for studying the activity of flavin-dependent oxidases and for the protein target profiling of monoamine oxidase inhibitors.
    Angewandte Chemie (International ed. in English), 2012, Jul-09, Volume: 51, Issue:28

    Topics: Brain Neoplasms; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Tumor Cells, Cultured

2012
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

    Topics: Ascorbic Acid; Brain; Brain Neoplasms; Catecholamines; Cell Line; Drug Interactions; Female; Humans; Levodopa; Male; Neuroblastoma; Parkinson Disease; Quinones; Selegiline

1993
Reduction in glial fibrillary acidic protein mRNA abundance induced by (-)-deprenyl and other monoamine oxidase B inhibitors in C6 glioma cells.
    Journal of neurochemistry, 1993, Volume: 61, Issue:4

    Topics: Animals; Brain Neoplasms; Dose-Response Relationship, Drug; Gene Expression; Glial Fibrillary Acidic Protein; Glioma; Monoamine Oxidase; Monoamine Oxidase Inhibitors; RNA, Messenger; Selegiline; Stereoisomerism; Time Factors; Tumor Cells, Cultured

1993
Monoamine oxidase-B in astrocytes.
    Glia, 1993, Volume: 8, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Astrocytes; Astrocytoma; Autoradiography; Biomarkers; Brain Neoplasms; Cells, Cultured; Cerebral Cortex; Emulsions; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Monoamine Oxidase; Neoplasm Proteins; Nerve Tissue Proteins; Rats; Selegiline; Spinal Cord

1993
Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl.
    Progress in brain research, 1995, Volume: 106

    Topics: Brain Neoplasms; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Glioma; Humans; Neuroblastoma; Oxidopamine; Selegiline; Tumor Cells, Cultured

1995